Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: Justification for K-ras-directed therapy

Jason B. Fleming, Guo Liang Shen, Shane E. Holloway, Mishel Davis, Rolf A. Brekken

Research output: Contribution to journalArticlepeer-review

156 Scopus citations

Fingerprint

Dive into the research topics of 'Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: Justification for K-ras-directed therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences